David Shaw’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,800
Closed -$506K 4828
2023
Q4
$506K Buy
+7,800
New +$470K ﹤0.01% 3504
2022
Q4
Sell
-30,118
Closed -$2.19M 5200
2022
Q3
$2.19M Buy
30,118
+16,120
+115% +$1.2M ﹤0.01% 2919
2022
Q2
$952K Buy
+13,998
New +$1.01M ﹤0.01% 3670
2021
Q4
Sell
-3,470
Closed -$281K 5779
2021
Q3
$281K Sell
3,470
-56,288
-94% -$4.73M ﹤0.01% 4398
2021
Q2
$5.57M Buy
59,758
+24,552
+70% +$2.38M ﹤0.01% 1946
2021
Q1
$3.77M Sell
35,206
-3,699
-10% -$384K ﹤0.01% 2074
2020
Q4
$3.4M Buy
+38,905
New +$2.75M ﹤0.01% 2168

Other funds holding NARI

David Shaw's NARI Position: Q1 2024 in Review

David Shaw sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2024, closing a stake of 7,800 shares — an estimated $506K sold.

David Shaw first reported a position in NARI in Q4 2020 and held it in 7 quarters. The position peaked at $5.57M in Q2 2021. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • David Shaw reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 7,800 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $506K.
  • David Shaw first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • David Shaw's Inari Medical, Inc. Common Stock position peaked at $5.57M in Q2 2021.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.